Computerized immunization record agreement in Araraquara, São Paulo, Brazil, 2018

Garcia, Érica Marvila; Murakami Junior, Jose; Costa, Ângela Aparecida; Inenami, Marta; Figueiredo, Walter Manso; Waldman, Eliseu Alves; Sato, Ana Paula Sayuri

Acessibilidade / Reportar erro

Brasil

Epidemiologia e Serviços de Saúde

Español English

Brasil

Español English

sumário « anterior atual seguinte »

Sumário

Original Article • Epidemiol. Serv. Saúde 30 (2) • 2021 • https://doi.org/10.1590/S1679-49742021000200023 copy

Computerized immunization record agreement in Araraquara, São Paulo, Brazil, 2018¹ 1 Article derived from the doctoral thesis entitled ‘Maternal vaccine hesitancy and the vaccination status of children up to two years old’, to be submitted by Erica Marvila Garcia to the Public Health Postgraduate Program of the School of Public Health of the University of São Paulo, in 2021. The study received financial support from the São Paulo State Research Foundation (FAPESP): Process No. 2017/14415-9.

Authorship SCIMAGO INSTITUTIONS RANKINGS

Abstract

Objective:

To describe agreement between the Juarez System immunization data and information in vaccination record booklets and vaccination coverage in children aged 12 to 24 months.

Methods:

This was a descriptive study to assess the vaccination status at 12 and 24 months of age of children born in 2015 and recorded on the Juarez System. The levels of agreement between the Juarez System data and the information in vaccination record booklets were verified.

Results:

429 children were included. It was found that agreement ranged between 84.1% and 99.1%. The vaccine survey found that coverage for each vaccine ranged from 86.01% to 100% and for the full schedule, from 77.1% (12 months) to 68.8% (24 months). The spatial distributions of vaccine coverage ranged from 28% to 100%.

Conclusion:

There was excellent agreement between the data, with high vaccination coverage, but heterogeneity in their spatial distributions.

Keywords:
Vaccination; Immunization Programs; Vaccination Coverage; Information Systems; Spatial Analysis

Vaccine	Dose	Minimum age	Interval between two doses	Minimum interval between two doses	Delay (with effect from)
Bacillus Calmette-Guérin	1	At birth	-	-	2^nd month
Attenuated poliomyelitis/ inactivated poliomyelitis	1	6 weeks	2 months	4 weeks	3^rd month
	2	10 weeks	2 months	4 weeks	5^th month
	3	14 weeks	9 months	6 months	7^th month
	Booster shot	6 months after the 3^rd dose	-	-	16^th month
Diphtheria, tetanus and pertussis	1	6 weeks	2 months	4 weeks	3^th month
	2	10 weeks	2 months	4 weeks	5^th month
	3	14 weeks	9 months	6 months	7^th month
	Booster shot	12 months	-	-	16^th month
Haemophilus influenzae type B	1	6 weeks	2 months	4 weeks	3^th month
	2	10 weeks	2 months	4 weeks	5^th month
	3	14 weeks	-	-	7^th month
Hepatitis B	1	At birth	2 months	4 weeks	2^nd month
	2	4 weeks	4 months	8 weeks	3^rd month
	3	24 weeks	-	-	7^th month
Human rotavirus	1	6 weeks	2 months	4 weeks	3^rd month
Human rotavirus	2	10 weeks	-	-	5^th month
Yellow fever	1	9 months	-	-	10^th month
Triple viral	1	12 months	-	-	13^th month
10-valent Pneumococcal	1	6 weeks	2 months	4 weeks	3^rd month
	2	10 weeks	2 months	4 weeks	5^th month
	Booster shot	12 months	-	-	16^th month
Meningococcal C	1	6 weeks	2 months	4 weeks	4^th month
	2	10 weeks	7 months	8 weeks	6^th month
	Booster shot	12 months	-	-	13^th month
Hepatitis A	1	12 months	-	-	16^th month

Vaccine	Vaccination record booklet	Juarez system	Difference (%)	Agreement (%)	Kappa coefficient	p-value^a
BCG^b	428	429	-0.2	97.9	0.9	<0.001
Hepatitis B at birth	429	427	0.5	97.4	0.9	<0.001
DTP^c/Hib^d/hepatitis B - 1^st dose	429	427	0.5	98.1	0.9	<0.001
DTP^c/Hib^d/hepatitis B - 2^nd dose	428	418	2.3	95.6	0.9	<0.001
DTP^c/Hib^d/hepatite B - 3^rd dose	426	422	0.9	94.1	0.9	<0.001
DTP^c - booster shot	415	406	2.1	92.2	0.9	<0.001
Poliomyelitis - 1^st dose	429	426	0.7	99.1	0.9	<0.001
Poliomyelitis - 2^nd dose	428	423	1.2	97.2	0.9	<0.001
Poliomyelitis - 3^rd dose	426	420	1.4	94.8	0.9	<0.001
Poliomyelitis - booster shot	417	487	-16.3	92.4	0.9	<0.001
Rotavirus - 1^st dose	424	421	0.7	97.8	0.9	<0.001
Rotavirus - 2^nd dose	414	411	0.7	96.6	0.9	<0.001
Pneumococcal - 1s^st dose	429	425	0.9	97.9	0.9	<0.001
Pneumococcal - 2^nd dose	426	423	0.7	97.2	0.9	<0.001
Pneumococcal - booster shot	424	391	7.7	84.1	0.8	<0.001
Meningococcal - 1^st dose	425	424	0.2	95.5	0.9	<0.001
Meningococcal - 2^st dose	422	422	0.0	92.8	0.9	<0.001
Meningococcal - booster shot	413	404	2.1	94.6	0.9	<0.001
Yellow fever	423	414	2.1	93.9	0.9	<0.001
Hepatitis A	427	409	4.2	93.6	0.9	<0.001
Measles/mumps/rubella - 1^st dose	427	414	3.0	94.7	0.9	<0.001
Measles/mumps/rubella - 2^nd dose	354	381	-6.3	92.6	0.9	<0.001
Chickenpox	393	379	3.3	95.7	0.9	<0.001

Secretaria de Vigilância em Saúde e Ambiente - Ministério da Saúde do Brasil SRTVN Quadra 701, Via W5 Norte, Lote D, Edifício P0700, CEP: 70719-040, +55 61 3315-3464, Fax: +55 61 3315-3464 - Brasília - DF - Brazil
E-mail: ress.svs@gmail.com

Acompanhe os números deste periódico no seu leitor de RSS

[1] Correspondence:
Érica Marvila Garcia - Universidade de São Paulo, Faculdade de Saúde Pública, Av. Dr. Arnaldo, No. 715, São Paulo, SP, Brazil. Postcode: 01246-904. E-mail: ericamarvila@usp.br